Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 687386, 11 pages
http://dx.doi.org/10.1155/2015/687386
Research Article

Zeaxanthin Inhibits Hypoxia-Induced VEGF Secretion by RPE Cells through Decreased Protein Levels of Hypoxia-Inducible Factors-1α

1Department of Ophthalmology, The New York Eye and Ear Infirmary of Mount Sinai Health System, 310 E. 14th Street, New York, NY 10003, USA
2Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Tissue Culture Center, The New York Eye and Ear Infirmary of Mount Sinai Health System, 310 E. 14th Street, New York, NY 10003, USA
4Department of Pathology, The New York Eye and Ear Infirmary of Mount Sinai Health System, 310 E. 14th Street, New York, NY 10003, USA

Received 3 September 2014; Accepted 15 December 2014

Academic Editor: Takashi Saku

Copyright © 2015 Richard Rosen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. B. Loureiro and P. A. D'Amore, “Transcriptional regulation of vascular endothelial growth factor in cancer,” Cytokine & Growth Factor Reviews, vol. 16, no. 1, pp. 77–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Xie, D. Wei, Q. Shi, and S. Huang, “Constitutive and inducible expression and regulation of vascular endothelial growth factor,” Cytokine and Growth Factor Reviews, vol. 15, no. 5, pp. 297–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Pournaras, J. W. Miller, E. S. Gragoudas et al., “Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina,” Archives of Ophthalmology, vol. 115, no. 12, pp. 1553–1558, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. A. N. Witmer, G. F. J. M. Vrensen, C. J. F. Van Noorden, and R. O. Schlingemann, “Vascular endothelial growth factors and angiogenesis in eye disease,” Progress in Retinal and Eye Research, vol. 22, no. 1, pp. 1–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Arjamaa, M. Nikinmaa, A. Salminen, and K. Kaarniranta, “Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD),” Ageing Research Reviews, vol. 8, no. 4, pp. 349–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Penn, A. Madan, R. B. Caldwell, M. Bartoli, R. W. Caldwell, and M. E. Hartnett, “Vascular endothelial growth factor in eye disease,” Progress in Retinal and Eye Research, vol. 27, no. 4, pp. 331–371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. W. Miller, A. P. Adamis, D. T. Shima et al., “Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model,” The American Journal of Pathology, vol. 145, no. 3, pp. 574–584, 1994. View at Google Scholar · View at Scopus
  8. N. Okamoto, T. Tobe, S. F. Hackett et al., “Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization,” The American Journal of Pathology, vol. 151, no. 1, pp. 281–291, 1997. View at Google Scholar · View at Scopus
  9. I. A. Pierce, R. L. Avery, E. D. Foley, L. P. Aiello, and L. E. H. Smith, “Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 3, pp. 905–909, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Wang, P. Geisen, E. S. Wittchen et al., “The role of RPE cell-associated VEGF189 in choroidal endothelial cell transmigration across the RPE,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 570–578, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. F. Bento, R. Fernandes, P. Matafome, C. Sena, R. Seia, and P. Pereira, “Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction,” Experimental Physiology, vol. 95, no. 9, pp. 955–970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W.-C. Wu, Y.-H. Kao, P.-S. Hu, and J.-H. Chen, “Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro,” Experimental Eye Research, vol. 85, no. 5, pp. 721–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Geisen, J. R. McColm, B. M. King, and M. E. Hartnett, “Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture,” Current Eye Research, vol. 31, no. 9, pp. 739–748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ghiso, R. M. Rohan, S. Amano, R. Garland, and A. P. Adamis, “Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP,” Investigative Ophthalmology & Visual Science, vol. 40, no. 6, pp. 1033–1039, 1999. View at Google Scholar · View at Scopus
  15. H. G. T. Blaauwgeers, G. M. Holtkamp, H. Rutten et al., “Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation,” The American Journal of Pathology, vol. 155, no. 2, pp. 421–428, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. K. B. Cullberg, J. Olholm, S. K. Paulsen et al., “Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro,” European Journal of Pharmaceutical Sciences, vol. 49, no. 2, pp. 251–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Forooghian, R. Razavi, and L. Timms, “Hypoxia-inducible factor expression in human RPE cells,” British Journal of Ophthalmology, vol. 91, no. 10, pp. 1406–1410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. H. Lin, C. H. Li, P. L. Liao et al., “Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway,” British Journal of Pharmacology, vol. 168, no. 4, pp. 920–931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Zhang, X. Zhang, X. Hao et al., “Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 5, pp. 633–639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhu, Y.-S. Wang, J. Zhang et al., “Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells,” Experimental Eye Research, vol. 88, no. 5, pp. 910–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Xiao, S. Zeng, M. Lv, and S. Ling, “Small hairpin loop RNA targeting HIF-1α down-regulates VEGF and up-regulates PEDF in human retinal pigment epithelial cells under hypoxic condition,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 28, no. 4, pp. 460–464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Xiao, S. Zeng, S. Ling, and M. Lv, “Up-regulation of HIF-1α and VEGF expression by elevated glucose concentration and hypoxia in cultured human retinal pigment epithelial cells,” Journal of Huazhong University of Science and Technology, vol. 26, no. 4, pp. 463–465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-C. Chen, C.-F. Lee, W.-H. Huang, and T.-C. Chou, “Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells,” Biochemical Pharmacology, vol. 85, no. 9, pp. 1278–1287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Z. Imtiyaz and M. C. Simon, “Hypoxia-inducible factors as essential regulators of inflammation,” Current Topics in Microbiology and Immunology, vol. 345, no. 1, pp. 105–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Brihimi-Horn and J. Pouysségur, “HIF at a glance,” Journal of Cell Science, vol. 122, no. 8, pp. 1055–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Weidemann and R. S. Johnson, “Biology of HIF-1α,” Cell Death & Differentiation, vol. 15, no. 4, pp. 621–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Sommerburg, J. E. E. Keunen, A. C. Bird, and F. J. G. M. van Kuijk, “Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes,” British Journal of Ophthalmology, vol. 82, no. 8, pp. 907–910, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Vishwanathan, M. Neuringer, D. Max Snodderly, W. Schalch, and E. J. Johnson, “Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates,” Nutritional Neuroscience, vol. 16, no. 1, pp. 21–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. E. J. Johnson, M. Neuringer, R. M. Russell, W. Schalch, and D. M. Snodderly, “Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys,” Investigative Ophthalmology and Visual Science, vol. 46, no. 2, pp. 692–702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. P. S. Bernstein, F. Khachik, L. S. Carvalho, G. J. Muir, D.-Y. Zhao, and N. B. Katz, “Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye,” Experimental Eye Research, vol. 72, no. 3, pp. 215–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Snodderly, G. J. Handelman, and A. J. Adler, “Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys,” Investigative Ophthalmology & Visual Science, vol. 32, no. 2, pp. 268–279, 1991. View at Google Scholar · View at Scopus
  32. S. S. Ahmed, M. N. Lott, and D. M. Marcus, “The macular xanthophylls,” Survey of Ophthalmology, vol. 50, no. 2, pp. 183–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Seddon, U. A. Ajani, R. D. Sperduto et al., “Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration,” The Journal of the American Medical Association, vol. 272, no. 18, pp. 1413–1420, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. L. Tan, J. J. Wang, V. Flood, E. Rochtchina, W. Smith, and P. Mitchell, “Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study,” Ophthalmology, vol. 115, no. 2, pp. 334–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. P. SanGiovanni, E. Y. Chew, T. E. Clemons et al., “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22,” Archives of Ophthalmology, vol. 125, no. 9, pp. 1225–1232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Michikawa, S. Ishida, Y. Nishiwaki et al., “Serum antioxidants and age-related macular degeneration among older Japanese,” Asia Pacific Journal of Clinical Nutrition, vol. 18, no. 1, pp. 1–7, 2009. View at Google Scholar · View at Scopus
  37. S. Beatty, U. Chakravarthy, J. M. Nolan et al., “Secondary outcomes in a clinical trial of Carotenoids with Coantioxidants versus placebo in early age-related macular degeneration,” Ophthalmology, vol. 120, no. 3, pp. 600–606, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Ho, R. van Leeuwen, J. C. M. Witteman et al., “Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam Study,” Archives of Ophthalmology, vol. 129, no. 6, pp. 758–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. F. M. Barker II, “Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts,” Current Medical Research and Opinion, vol. 26, no. 8, pp. 2011–2023, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. The Age-Related Eye Disease Study 2 (AREDS2) Research Group, “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial,” The Journal of the American Medical Association, vol. 309, no. 19, pp. 2005–2015, 2013. View at Publisher · View at Google Scholar
  41. L. Ma, H.-L. Dou, Y.-Q. Wu et al., “Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis,” British Journal of Nutrition, vol. 107, no. 3, pp. 350–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Bian, S. Gao, J. Zhou et al., “Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells,” Free Radical Biology and Medicine, vol. 53, no. 6, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Bhosale, B. Serban, Y. Z. Da, and P. S. Bernstein, “Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica,” Biochemistry, vol. 46, no. 31, pp. 9050–9057, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. R. Kim, K. Nakanishi, Y. Itagaki, and J. R. Sparrow, “Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin,” Experimental Eye Research, vol. 82, no. 5, pp. 828–839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. E. G. Nilsson, S. P. Sundelin, U. Wihlmark, and U. T. Brunk, “Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage,” Documenta Ophthalmologica, vol. 106, no. 1, pp. 13–16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. J. Chucair, N. P. Rotstein, J. P. SanGiovanni, A. During, E. Y. Chew, and L. E. Politi, “Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5168–5177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Loane, J. M. Nolan, O. O'Donovan, P. Bhosale, P. S. Bernstein, and S. Beatty, “Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration,” Survey of Ophthalmology, vol. 53, no. 1, pp. 68–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Tanaka, M. Shnimizu, and H. Moriwaki, “Cancer chemoprevention by carotenoids,” Molecules, vol. 17, no. 3, pp. 3202–3242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. R. A. Kowluru, B. Menon, and D. L. Gierhart, “Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats,” Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1645–1651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Fernández-Robredo, S. Recalde, G. Arnáiz et al., “Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-e deficient mice,” Current Eye Research, vol. 34, no. 7, pp. 543–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. J. M. Berendschot, “Lutein: More than just a filter for blue light,” Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. D.-N. Hu, H. E. Savage, and J. E. Roberts, “Uveal melanocytes, ocular pigment epithelium, and Müller cells in culture: in vitro toxicology,” International Journal of Toxicology, vol. 21, no. 6, pp. 465–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. W.-C. Wu, D.-N. Hu, H.-X. Gao et al., “Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells,” Molecular Vision, vol. 16, pp. 1864–1873, 2010. View at Google Scholar · View at Scopus
  54. D.-N. Hu, S. A. McCormick, R. Ritch, and K. Pelton-Henrion, “Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes,” Investigative Ophthalmology & Visual Science, vol. 34, no. 7, pp. 2210–2219, 1993. View at Google Scholar · View at Scopus
  55. X. Dong, Y.-S. Wang, G.-R. Dou et al., “Influence of dll4 via hif-1α-vegf signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions,” PLoS ONE, vol. 6, no. 4, Article ID e18481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Notari, A. Miller, A. Martínez et al., “Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia,” Investigative Ophthalmology and Visual Science, vol. 46, no. 8, pp. 2736–2747, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Wang, Y. Zou, Z.-L. Yuan, and J.-G. Xiao, “Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells,” Journal of Ocular Pharmacology and Therapeutics, vol. 19, no. 5, pp. 457–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. Cui, E. Song, D.-N. Hu, M. Chen, R. Rosen, and S. A. McCormick, “Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway,” Current Eye Research, vol. 37, no. 8, pp. 730–739, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. Zhang, J. Yan, Y. Chang, S. ShiDu Yan, and H. Shi, “Hypoxia inducible factor-1 as a target for neurodegenerative diseases,” Current Medicinal Chemistry, vol. 18, no. 28, pp. 4335–4343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-H. Oh, A. Togloom, S.-W. Kim, and K. Huh, “Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia,” Current Eye Research, vol. 38, no. 10, pp. 1072–1082, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. M. M. Sanz, L. E. Johnson, S. Ahuja, P. A. R. Ekström, J. Romero, and T. van Veen, “Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration,” Neuroscience, vol. 145, no. 3, pp. 1120–1129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. R. J. Olk, E. Peralta, S. Sayegh, and D. L. Gierhart, “Does Oral zeaxanthin improve the anatomic and visual outcome of triple therapy for subfoveal choroidal CNV in age related macular degeneration (ARMD),” in Proceedings of the 44th Retina Society Meeting, Poster no. 17, Rome, Italy, 2011.
  63. K. Manousaridis and J. Talks, “Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?” British Journal of Ophthalmology, vol. 96, no. 2, pp. 179–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. Â. M. Carneiro, R. Costa, M. S. Falcão et al., “Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab,” Acta Ophthalmologica, vol. 90, no. 1, pp. e25–e30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Semeraro, F. Morescalchi, F. Parmeggiani, B. Arcidiacono, and C. Costagliola, “Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration,” Current Vascular Pharmacology, vol. 9, no. 5, pp. 629–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Christoforidis, R. Ricketts, C. Pratt et al., “The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model,” Clinical Ophthalmology, vol. 6, no. 1, pp. 61–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. H. R. Rezvani, N. Ali, L. J. Nissen et al., “HIF-1α in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders,” Journal of Investigative Dermatology, vol. 131, no. 9, pp. 1793–1805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Nuzzi and F. Tridico, “Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study,” Seminars in Ophthalmology, 2013. View at Publisher · View at Google Scholar
  69. S. Day, K. Acquah, P. Mruthyunjaya, D. S. Grossman, P. P. Lee, and F. A. Sloan, “Ocular complications after antivascular endothelial growth factor therapy in medicare patients with age-related macular degeneration,” The American Journal of Ophthalmology, vol. 152, no. 2, pp. 266–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Y. Choi, M. C. Ortube, C. A. McCannel et al., “Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib,” Retina, vol. 31, no. 6, pp. 1028–1035, 2011. View at Publisher · View at Google Scholar · View at Scopus